Eventually, 10 potential TAA targets were investigated from 75 HCC driver genes, including p16, SETDB1, RNA helicase A, BRG1, GNAS, Merlin, DNMT3A, NRAS, GMPS, and ERK2 (Table 2). This evidence concerns the gene NRAS and hepatocellular carcinoma.